Paper · 42839237

Triglyceride-glucose index as a cardiovascular risk marker: updated evidence, limitations, and future perspectives.

Cherska M and 6 others. Lipids Health Dis, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Triglyceride-glucose index as a cardiovascular risk marker: updated evidence, limitations, and future perspectives. Papers, record 42839237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42839237

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Triglyceride-glucose index as a cardiovascular risk marker: updated evidence, limitations, and future perspectives.
Journal: Lipids Health Dis
Year: 2026
Publication types: Journal Article, Review
PubMed: https://pubmed.ncbi.nlm.nih.gov/42839237/
DOI: https://doi.org/10.1186/s12944-026-03036-8
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13640206/
The journal: https://conductscience.org/library/journal-index/101147696
Revised in PubMed: 2026-10-08

Source PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Cherska M	Mariia
2	Kukharchuk K	Khrystyna
3	Ceasovschih A	Alexandr
4	Sorodoc V	Victorita
5	Fogacci F	Federica
6	Storozhenko T	Tatyana
7	Abd El-Aty AM	A M

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Triglycerides	Major topic
Cardiovascular Diseases	Major topic
Blood Glucose	Major topic
Humans
Insulin Resistance
Biomarkers
Risk Factors
Diabetes Mellitus, Type 2
Prognosis
Heart Disease Risk Factors
Female

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	36,967,464	Insulin Resistance Indices and Carotid Intima-media Thickness in Physically Fit Adults: CHIEF Atherosclerosis Study.	Endocr Metab Immune Disord Drug Targets	2023	https://conductscience.org/library/papers/36967464	PubMed
2	34,222,388	Triglyceride-Glucose Index and Extracellular Volume Fraction in Patients With Heart Failure.	Front Cardiovasc Med	2021	https://conductscience.org/library/papers/34222388	PubMed
3	24,402,298	Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.	J Investig Med	2014	https://conductscience.org/library/papers/24402298	PubMed
4	33,456,363	A high triglyceride-glucose index is associated with left ventricular dysfunction and atherosclerosis.	Int J Med Sci	2021	https://conductscience.org/library/papers/33456363	PubMed
5	27,081,110	Cardiovascular Disease in Women: Clinical Perspectives.	Circ Res	2016	https://conductscience.org/library/papers/27081110	PubMed
6	40,859,224	The triglyceride-glucose index: updating evidence from clinical settings to molecular mechanisms in ageing-related cerebrovascular diseases.	Cardiovasc Diabetol	2025	https://conductscience.org/library/papers/40859224	PubMed
7	41,752,760	Association of the Triglyceride-Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis.	Medicina (Kaunas)	2026	https://conductscience.org/library/papers/41752760	PubMed
8	37,114,217	Predictive Effect of Triglyceride-Glucose Index on Adverse Prognostic Events in Patients with Type 2 Diabetes Mellitus and Ischemic Cardiomyopathy.	Diabetes Metab Syndr Obes	2023	https://conductscience.org/library/papers/37114217	PubMed
9	36,329,456	Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis.	Cardiovasc Diabetol	2022	https://conductscience.org/library/papers/36329456	PubMed
10	36,521,498	Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study.	Lancet Healthy Longev	2023	https://conductscience.org/library/papers/36521498	PubMed

1 to 10 of 82

See all 82 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42839237

GET https://conductscience.org/api/papers/v1/42839237/references?page=2

API reference For AI assistants